Israel Corporation Ltd
General ticker "IRLCF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $18.7B (TTM average)
Israel Corporation Ltd does not follow the US Stock Market performance with the rate: -30.5%.
Estimated limits based on current volatility of 0.0%: low 27.91$, high 27.91$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-04-14, amount 0.17$ (Y0.61%)
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [158.41$, 261.42$]
- 2026-12-31 to 2027-12-31 estimated range: [150.51$, 248.67$]
Financial Metrics affecting the IRLCF estimates:
- Negative: with PPE of 205.3 at the end of fiscal year the price was high
- Positive: 4.60 < Operating profit margin, % of 7.47
- Positive: 4.90 < Operating cash flow per share per price, % of 5.45
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 2.08
- Positive: 12.78 < Shareholder equity ratio, % of 22.16 <= 25.20
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 5.08
- Positive: 2.08 < Industry earnings per price (median), % of 2.85
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Negative: 0 < Inventory ratio change, % of 0.23
Short-term IRLCF quotes
Long-term IRLCF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7,536.00MM | $6,841.00MM | $7,742.91MM |
| Operating Expenses | $6,409.00MM | $6,081.00MM | $7,164.87MM |
| Operating Income | $1,127.00MM | $760.00MM | $578.04MM |
| Non-Operating Income | $-165.00MM | $-129.00MM | $-117.99MM |
| Interest Expense | $203.00MM | $189.98MM | $203.50MM |
| R&D Expense | $71.00MM | $69.00MM | $75.77MM |
| Income(Loss) | $962.00MM | $631.00MM | $460.05MM |
| Taxes | $287.00MM | $157.00MM | $171.03MM |
| Net Income(Loss)* | $273.00MM | $190.00MM | $94.17MM |
| Stockholders Equity | $2,776.00MM | $2,816.00MM | $3,012.63MM |
| Inventory | $1,703.00MM | $1,626.00MM | $1,934.40MM |
| Assets | $12,891.00MM | $12,490.00MM | $13,592.82MM |
| Operating Cash Flow | $1,822.00MM | $1,423.00MM | $973.14MM |
| Capital expenditure | $780.00MM | $713.00MM | $891.96MM |
| Investing Cash Flow | $-1,096.00MM | $-343.00MM | $-960.15MM |
| Financing Cash Flow | $-931.00MM | $-979.00MM | $-138.56MM |
| Earnings Per Share** | $3.58 | $2.53 | $1.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.